Fresh Tracks Therapeutics Current Assets

Fresh Tracks Therapeutics (FRTX) currently reports a current assets of $12M as of December 2023. That compares with $10M in the prior-year period — up 14.6% year over year. Use the charts on this page to explore Fresh Tracks Therapeutics's current assets history and peer comparisons.

Fresh Tracks Therapeutics's current assets increased from $10M to $12M — a 14.6% year-over-year increase (period ending December 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Fresh Tracks Therapeutics reported $12M in current assets as of December 2023. That compares with $10M in the prior-year period — up 14.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $12M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Fresh Tracks Therapeutics, and consider following FRTX for alerts when major investors trade the stock.

Fresh Tracks Therapeutics is classified in the Healthcare sector. On current assets, it currently shows $12M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing FRTX with unrelated industries.